Improving Quality of Life and Function for Older Cancer Patients Receiving Radiotherapy

NCT03071640 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 302

Last updated 2021-12-10

No results posted yet for this study

Summary

This study is a first part of a larger project aiming at improving the following outcomes in older cancer patients receiving external beam radiation therapy (EBRT): quality of life, functioning and need for professional help (dependency). To achieve this, the investigators will develop and test a geriatric assessment (GA) with management (GAM) intervention targeting patients at risk of negative outcomes as defined. The problems and needs that older patients experience before, during and after EBRT are poorly described. Furthermore, although GA is the recommended approach to assess older cancer patients' vulnerability, very few studies have investigated its benefit and feasibility in a radiotherapy setting and there is no universal recipe for how an efficient GAM intervention should be applied in this setting. Before defining and testing an intervention, the investigators will therefore conduct an observational study addressing older patients \>= 65 years referred for either palliative or curative EBRT. The main objectives are to identify patients at risk for negative outcomes, and to test the feasibility of GA in the community service and at a radiotherapy department.

Conditions

  • Elderly
  • Cancer
  • Radiotherapy Side Effect

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    collaborator OTHER
  • St. Olavs Hospital

    collaborator OTHER
  • Oslo University Hospital

    collaborator OTHER
  • Oslo Metropolitan University

    collaborator OTHER
  • Sykehuset Innlandet HF

    lead OTHER

Principal Investigators

  • Marit Jordhøy · Sykehuset Innlandet HF

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-22
Primary Completion
2018-08-13
Completion
2020-07-19

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03071640 on ClinicalTrials.gov